Several brokerages have updated their recommendations and price targets on shares of AstraZeneca plc (LON: AZN) in the last few weeks: 7/4/2016 – AstraZeneca plc had its “underperform” rating reaffirmed by analysts at Credit Suisse Group AG. They now have a GBX 4,000 ($53.13) price target on the stock. 7/3/2016 – AstraZeneca plc had its […]